NET LOSS PER COMMON SHARE - Additional Information (Details) - shares |
3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
Nov. 30, 2022 |
|
| Stock Options and Nonvested Restricted Share | |||||
| Antidilutive Units | |||||
| Antidilutive securities excluded from computation of earnings per share, amount (in shares) | 700,000 | 900,000 | 700,000 | 700,000 | |
| Pre-Funded Warrants | Follow-on Offering | |||||
| Antidilutive Units | |||||
| Number of securities called by warrants or rights (in shares) | 416,673 | 416,673 | |||